Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Non Operating Income (2016 - 2025)

Marimed has reported Non Operating Income over the past 10 years, most recently at -$2.8 million for Q4 2025.

  • Quarterly Non Operating Income fell 51.68% to -$2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.8 million through Dec 2025, up 20.97% year-over-year, with the annual reading at -$8.0 million for FY2025, 16.89% down from the prior year.
  • Non Operating Income was -$2.8 million for Q4 2025 at Marimed, down from $19000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $1.8 million in Q4 2021 and troughed at -$2.8 million in Q4 2025.
  • The 5-year median for Non Operating Income is -$292500.0 (2022), against an average of -$463222.2.
  • Year-over-year, Non Operating Income soared 165.75% in 2022 and then plummeted 2239.24% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $1.8 million in 2021, then plummeted by 118.43% to -$334000.0 in 2022, then skyrocketed by 76.35% to -$79000.0 in 2023, then plummeted by 2239.24% to -$1.8 million in 2024, then plummeted by 51.68% to -$2.8 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Non Operating Income are -$2.8 million (Q4 2025), $19000.0 (Q3 2025), and $17000.0 (Q2 2025).